Effect of Pike oil in healthy subjects as phase II and III study

Effect of Pike oil in healthy subjects as phase II and III study - Phase II/III study for pike oil benefits

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000029181

Enrollment

Registered

2017-09-18

Start date

2017-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adults Healthy subjects

Interventions

4 weeks intake of pike oil 4 weeks intake of placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: <=20,<60 years healthy subjects

Exclusion criteria

Exclusion criteria: patients who diagnosed/treated lipid abnormal or any disease

Design outcomes

Primary

Measure	Time frame
Improvement of FMD levels	—

Countries

Japan

Contacts

Public ContactRie Tsutsumi

Tokushima University Nutrition and Metabolism

rtsutsumi@tokushima-u.ac.jp088-633-9249

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026